Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Amphastar Pharmaceuticals Inc (NASDAQ:AMPH)

19.14
BATS BZX Real-Time Price
As of 11:47am ET
 +0.30 / +1.59%
Today’s Change
10.50
Today|||52-Week Range
21.53
+34.50%
Year-to-Date
Allergan Gets FDA Approval for New Line of Breast Implants
Sep 26 / Zacks.com - Paid Partner Content
AngioDynamics Hits New 52-Week High on Solid Q4 Results
Sep 22 / Zacks.com - Paid Partner Content
Allergan/Adamas Launch New Dosage Strengths of Namzaric
Sep 23 / Zacks.com - Paid Partner Content
Why Amphastar Pharmaceuticals, Inc. is Soaring Today
Sep 20 / MotleyFool.com - Paid Partner Content
athenahealth Unveils athenaInsight, Focuses on Opioid Abuse
Sep 22 / Zacks.com - Paid Partner Content
Teva Presents Top-Line Data from Huntington Disease Study
Sep 20 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close18.84
Today’s open18.73
Day’s range18.73 - 19.17
Volume8,612
Average volume (3 months)517,666
Market cap$850.1M
Dividend yield--
Data as of 11:47am ET, 09/30/2016

Growth & Valuation

Earnings growth (last year)+76.00%
Earnings growth (this year)+513.33%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+19.51%
P/E ratio61.8
Price/Sales2.54
Price/Book2.88

Competitors

 Today’s
change
Today’s
% change
CLLSCellectis SA+0.13+0.54%
INSMInsmed Inc+0.41+2.94%
INSYINSYS Therapeutics I...-0.31-2.57%
MACKMerrimack Pharmaceut...+0.15+2.40%
Data as of 11:49am ET, 09/30/2016

Financials

Next reporting dateNovember 10, 2016
EPS forecast (this quarter)$0.03
Annual revenue (last year)$251.5M
Annual profit (last year)-$2.8M
Net profit margin-1.11%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman, COO &
Chief Scientist
Zi Ping Luo
CEO, Class III Director &
Chief Science Officer
Yong Feng Zhang
Corporate headquarters
Rancho Cucamonga, California

Forecasts

Search for Jobs